98 related articles for article (PubMed ID: 10333454)
1. In-vitro anti-proliferative effects of some anti-tumour drugs on feline mammary tumour cell lines.
Muleya JS; Nakaichi M; Taura Y; Yamaguchi R; Nakama S
Res Vet Sci; 1999 Jun; 66(3):169-74. PubMed ID: 10333454
[TBL] [Abstract][Full Text] [Related]
2. In vitro growth inhibition of cisplatin-resistant human lung cancer cell lines by recombinant human tumor necrosis factor and/or recombinant human interferon-gamma by virtue of collateral sensitivity.
Hong WS; Saijo N; Sasaki Y; Shinkai T; Eguchi K; Sakurai M; Takahashi H; Nakano H; Nakagawa K; Twentyman PR
Jpn J Cancer Res; 1987 Nov; 78(11):1274-80. PubMed ID: 3121562
[TBL] [Abstract][Full Text] [Related]
3. [Inhibitory effect of tumor necrosis factor and interferon with chemotherapeutic drugs on the growth of cancer cell of tongue].
Qu XR; Shen ZH; He ZM
Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):421-2. PubMed ID: 12206026
[No Abstract] [Full Text] [Related]
4. Synergistic cytotoxicity of recombinant human TNF and various anti-cancer drugs.
Watanabe N; Niitsu Y; Yamauchi N; Ohtsuka Y; Sone H; Neda H; Maeda M; Urushizaki I
Immunopharmacol Immunotoxicol; 1988; 10(1):117-27. PubMed ID: 2452179
[TBL] [Abstract][Full Text] [Related]
5. Effect of recombinant feline interferon-omega alone and in combination with chemotherapeutic agents on putative tumour-initiating cells and daughter cells derived from canine and feline mammary tumours.
Penzo C; Ross M; Muirhead R; Else R; Argyle DJ
Vet Comp Oncol; 2009 Dec; 7(4):222-9. PubMed ID: 19891692
[TBL] [Abstract][Full Text] [Related]
6. [Cytotoxicity of recombinant human tumor necrosis factor (rHTNF) alone and in combination with chemotherapeutic agents on human ovarian cancer cells].
Zhao EF
Zhonghua Fu Chan Ke Za Zhi; 1993 Mar; 28(3):153-6, 188. PubMed ID: 8354095
[TBL] [Abstract][Full Text] [Related]
7. Synergistic antitumor activity of TRAIL combined with chemotherapeutic agents in A549 cell lines in vitro and in vivo.
Fan QL; Zou WY; Song LH; Wei W
Cancer Chemother Pharmacol; 2005 Feb; 55(2):189-96. PubMed ID: 15290100
[TBL] [Abstract][Full Text] [Related]
8. Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.
Cuello M; Ettenberg SA; Nau MM; Lipkowitz S
Gynecol Oncol; 2001 Jun; 81(3):380-90. PubMed ID: 11371126
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant neuroblastoma tumour cells to endothelium.
Blaheta RA; Michaelis M; Natsheh I; Hasenberg C; Weich E; Relja B; Jonas D; Doerr HW; Cinatl J
Br J Cancer; 2007 Jun; 96(11):1699-706. PubMed ID: 17505515
[TBL] [Abstract][Full Text] [Related]
10. TNF-alpha augments intratumoural concentrations of doxorubicin in TNF-alpha-based isolated limb perfusion in rat sarcoma models and enhances anti-tumour effects.
van der Veen AH; de Wilt JH; Eggermont AM; van Tiel ST; Seynhaeve AL; ten Hagen TL
Br J Cancer; 2000 Feb; 82(4):973-80. PubMed ID: 10732774
[TBL] [Abstract][Full Text] [Related]
11. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
[TBL] [Abstract][Full Text] [Related]
12. Involvement of both intrinsic and extrinsic pathways in IFN-gamma-induced apoptosis that are enhanced with cisplatin.
Barton C; Davies D; Balkwill F; Burke F
Eur J Cancer; 2005 Jul; 41(10):1474-86. PubMed ID: 15949937
[TBL] [Abstract][Full Text] [Related]
13. Combined effect of alkyl-lysophospholipid and vincristine on proliferation, migration and invasion in human glioma cell lines in vitro.
Haugland HK; Nygaard SJ; Tysnes OB
Anticancer Res; 1999; 19(1A):149-56. PubMed ID: 10226536
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of antineoplastic effects by the combination of recombinant human tumor necrosis factor and mitoxantrone on primary culture of human ovarian cancer cells.
Cimoli G; Valenti M; Venturini M; Conte P; Russo P
Anticancer Res; 1992; 12(5):1411-4. PubMed ID: 1444198
[TBL] [Abstract][Full Text] [Related]
15. Suppression of vincristine-mediated cytotoxic activity by mitoxantrone in human cell lines.
Ho CK; Au LC; Wang SY
Anticancer Res; 1996; 16(5A):2645-51. PubMed ID: 8917364
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid.
Hougardy BM; van der Zee AG; van den Heuvel FA; Timmer T; de Vries EG; de Jong S
Gynecol Oncol; 2005 May; 97(2):353-64. PubMed ID: 15863130
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines.
Hashitani S; Urade M; Nishimura N; Maeda T; Takaoka K; Noguchi K; Sakurai K
Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity.
Mattarollo SR; Kenna T; Nieda M; Nicol AJ
Cancer Immunol Immunother; 2007 Aug; 56(8):1285-97. PubMed ID: 17265022
[TBL] [Abstract][Full Text] [Related]
19. Establishment of two vaccine-associated feline sarcoma cell lines and determination of in vitro chemosensitivity to doxorubicin and mitoxantrone.
Williams LE; Banerji N; Klausner JS; Kapur V; Kanjilal S
Am J Vet Res; 2001 Sep; 62(9):1354-7. PubMed ID: 11560259
[TBL] [Abstract][Full Text] [Related]
20. Potential role of transforming growth factor beta1 in drug resistance of tumor cells.
Stoika R; Yakymovych M; Souchelnytskyi S; Yakymovych I
Acta Biochim Pol; 2003; 50(2):497-508. PubMed ID: 12833174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]